Health Care & Life Sciences » Biotechnology | Japan Tissue Engineering Co. Ltd.

Japan Tissue Engineering Co. Ltd. | Income Statement

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
Sales/Revenue
1,008
1,321
1,431
2,135
2,272
Cost of Goods Sold (COGS) incl. D&A
585
838
924
944
977
Gross Income
423
483
507
1,191
1,294
SG&A Expense
1,413
1,348
1,395
843
1,047
EBIT
1,028
917
953
303
206
Non Operating Income/Expense
215
241
49
2
3
Interest Expense
11
11
-
-
-
Pretax Income
824
687
898
310
213
Income Tax
4
4
217
34
15
Consolidated Net Income
828
691
682
276
228
Net Income
828
691
682
276
228
Net Income After Extraordinaries
828
691
682
276
228
Net Income Available to Common
828
691
682
276
228
EPS (Basic)
22.54
18.21
16.79
6.81
5.61
Basic Shares Outstanding
37
38
41
41
41
EPS (Diluted)
22.54
18.21
16.79
6.81
5.61
Diluted Shares Outstanding
37
38
41
41
41
EBITDA
937
827
807
425
328
Other Operating Expense
38
52
64
45
42
Non-Operating Interest Income
-
-
6
5
5

About Japan Tissue Engineering Co.

View Profile
Address
6-209-1 Miyakitadori
Gamagori Aichi 443
Japan
Employees -
Website http://www.jpte.co.jp
Updated 09/14/2018
Japan Tissue Engineering Co., Ltd. engages in the research, development, and manufacture of cultured biological cells and tissues. It operates through the Regenerative Medicine, Custom Development and Manufacturing, and Research and Development (R&D) Support segments. The Regenerative Medicine segment develops, manufactures, and sells tissue-engineered medical products through autologous culturing techniques.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.